Obesity surgery: Happy with less or eternally hungry?

Trends in Endocrinology and Metabolism

Volumn 24, Issue 2, 2013, Pages 101-108

  Shin, Andrew C ^a   Berthoud, Hans Rudolf ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Brain; Food reward; Hypothalamus; Obesity surgery; Roux en Y gastric bypass surgery

Indexed keywords

MELANOCORTIN; MELANOCORTIN 4 RECEPTOR;

BARIATRIC SURGERY; BEHAVIOR CHANGE; BODY WEIGHT; BRAIN FUNCTION; CALORIC INTAKE; CALORIC RESTRICTION; COGNITION; CONCENTRATION RESPONSE; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD DEPRIVATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTRIC BANDING; GENETIC SUSCEPTIBILITY; HUMAN; HUNGER; HYPOTHALAMUS; NONHUMAN; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; REWARD; SLEEVE GASTRECTOMY; STOMACH BYPASS; TASTE PREFERENCE; WEIGHT; WEIGHT CHANGE; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

BARIATRIC SURGERY; HUMANS; HYPOTHALAMUS; MODELS, BIOLOGICAL; OBESITY;

EID: 84873132026     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.11.009     Document Type: Review

References (92)

1. Mingrone G., et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 2012, 366:1577-1585.
2. Schauer P.R., et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med. 2012, 366:1567-1576.
3. Brobeck J.R. Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol. Rev. 1946, 26:541-559.
4. Schwartz M.W., et al. Central nervous system control of food intake. Nature 2000, 404:661-671.
5. Cowley M.A., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411:480-484.
6. Luquet S., et al. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 310:683-685.
7. Krashes M.J., et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 2011, 121:1424-1428.
8. Morton G.J., et al. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
9. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 52:948-956.
10. Riediger T., et al. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 2004, 79:317-326.
11. Berthoud H-R. Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev. 2002, 26:393-428.
12. Berthoud H.R., Morrison C. The brain, appetite, and obesity. Annu. Rev. Psychol. 2008, 59:55-92.
13. Grill H.J., Hayes M.R. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab. 2012, 16:296-309.
14. Hayes M.R., et al. Caudal brainstem processing is sufficient for behavioral, sympathetic and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 2008, 149:4059-4068.
15. De Souza C.T., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
16. Thaler J.P., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122:153-162.
17. Williams L.M. Hypothalamic dysfunction in obesity. Proc. Nutr. Soc. 2012, 71:521-533.
18. Rosenbaum M., et al. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J. Clin. Invest. 2008, 118:2583-2591.
19. Schultes B., et al. Hedonic hunger is increased in severely obese patients and is reduced after gastric bypass surgery. Am. J. Clin. Nutr. 2010, 92:277-283.
20. Miras A.D., et al. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am. J. Clin. Nutr. 2012, 96:467-473.
21. Paulsen S.J., et al. Gene expression profiling of individual hypothalamic nuclei from single animals using laser capture microdissection and microarrays. J. Neurosci. Methods 2009, 177:87-93.
22. Nadreau E., et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int. J. Obes. (Lond.) 2006, 30:419-429.
23. Warne J.P., et al. Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet. Ann. Surg. 2009, 249:269-276.
24. Romanova I.V., et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J. Am. Coll. Surg. 2004, 199:887-895.
25. Stefater M.A., et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010, 138:2426-2436. 2436 e2421-e2423.
26. Balthasar N., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123:493-505.
27. Butler A.A., Cone R.D. Knockout models resulting in the development of obesity. Trends Genet. 2001, 17:S50-S54.
28. Hatoum I.J., et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J. Clin. Endocrinol. Metab. 2012, 97:E1023-E1031.
29. Mul J.D., et al. Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E103-E110.
30. Aslan I.R., et al. Bariatric surgery in a patient with complete MC4R deficiency. Int. J. Obes. (Lond.) 2011, 35:457-461.
31. Potoczna N., et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J. Gastrointest. Surg. 2004, 8:971-981.
32. Aslan I.R., et al. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes. Surg. 2011, 21:930-934.
33. Mirshahi U.L., et al. The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J. Clin. Endocrinol. Metab. 2011, 96:E2088-E2096.
34. Goergen M., et al. Influence of obesity-susceptibility loci (MC4R and INSIG2) on the outcome of weight loss and amelioration of co-morbidity in obese patients treated by a gastric-bypass. Bull. Soc. Sci. Med. Grand. Duche Luxemb. 2011, 7-24.
35. Still C.D., et al. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity (Silver Spring) 2011, 19:1676-1683.
36. Parikh M., et al. Frequencies of obesity susceptibility alleles among ethnically and racially diverse bariatric patient populations. Surg. Obes. Relat. Dis. 2012, 10.1016/j.soard.2012.04.004.
37. Schultes B., et al. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur. J. Endocrinol. 2009, 161:201-206.
38. Bingham N.C., et al. Bariatric surgery in hypothalamic obesity. Front. Endocrinol. (Lausanne) 2012, 3:23.
39. Meirelles K., et al. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann. Surg. 2009, 249:277-285.
40. Kelley D.E., et al. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 2004, 27:33-40.
41. Berthoud H.R. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol. Motil. 2008, 20(Suppl. 1):64-72.
42. Shin A.C., et al. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010, 151:1588-1597.
43. Korner J., et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg. Obes. Relat. Dis. 2007, 3:597-601.
44. Chambers A.P., et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011, 141:950-958.
45. le Roux C.W., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann. Surg. 2007, 246:780-785.
46. Sandoval D.A., et al. Arcuate GLP-1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008, 57:2046-2054.
47. Briggs D.I., et al. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151:4745-4755.
48. Chambers A.P., et al. The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology 2012, 10.1053/j.gastro.2012.09.009.
49. Jansen P.L., et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig. Dis. 2011, 29:48-51.
50. Pournaras D.J., et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012, 153:3613-3619.
51. Simonen M., et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes. Surg. 2012, 22:1473-1480.
52. Cummings B.P., et al. Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology 2012, 153:3620-3632.
53. Porez G., et al. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J. Lipid Res. 2012, 53:1723-1737.
54. Keitel V., et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 2010, 58:1794-1805.
55. Castro-Caldas M., et al. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. Mol. Neurobiol. 2012, 46:475-486.
56. Schubring S.R., et al. The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABA(A) receptors. Neurosci. Lett. 2012, 506:322-326.
57. Ozcan L., et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009, 9:35-51.
58. Sarruf D.A., et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010, 59:1817-1824.
59. Wu A.L., et al. Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1. Sci. Transl. Med. 2011, 3:113ra126.
60. Kralisch S., Fasshauer M. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:354-359.
61. Sun H.D., et al. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E964-E976.
62. Watanabe M., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
63. Thomas C., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10:167-177.
64. Shin A.C., et al. An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol. Behav. 2009, 97:572-580.
65. Speakman J.R., et al. Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity. Dis. Model Mech. 2011, 4:733-745.
66. Leinninger G.M., et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab. 2009, 10:89-98.
67. Opland D.M., et al. Modulation of the mesolimbic dopamine system by leptin. Brain Res. 2010, 1350:65-70.
68. Leinninger G.M., et al. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metab. 2011, 14:313-323.
69. Dossat A.M., et al. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 2011, 31:14453-14457.
70. Skibicka K.P., et al. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
71. Konner A.C., et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 2011, 13:720-728.
72. Speed N., et al. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS ONE 2011, 6:e25169.
73. Dunn J.P., et al. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care 2012, 35:1105-1111.
74. Berthoud H.R. Interactions between the 'cognitive' and 'metabolic' brain in the control of food intake. Physiol. Behav. 2007, 91:486-498.
75. Berridge K.C., et al. Dissecting components of reward: 'liking', 'wanting', and learning. Curr. Opin. Pharmacol. 2009, 9:65-73.
76. Kenler H.A., et al. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am. J. Clin. Nutr. 1990, 52:87-92.
77. Olbers T., et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann. Surg. 2006, 244:715-722.
78. Thirlby R.C., et al. Effect of Roux-en-Y gastric bypass on satiety and food likes: the role of genetics. J. Gastrointest. Surg. 2006, 10:270-277.
79. Burge J.C., et al. Changes in patients' taste acuity after Roux-en-Y gastric bypass for clinically severe obesity. J. Am. Diet. Assoc. 1995, 95:666-670.
80. Ochner C.N., et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann. Surg. 2011, 253:502-507.
81. Steele K.E., et al. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes. Surg. 2010, 20:369-374.
82. Dunn J.P., et al. Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res. 2010, 1350:123-130.
83. Shin A.C., et al. Roux-en-Y gastric bypass surgery changes food reward in rats. Int. J. Obes. (Lond.) 2011, 35:642-651.
84. Hajnal A., et al. Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G967-G979.
85. Tichansky D.S., et al. Decrease in sweet taste in rats after gastric bypass surgery. Surg. Endosc. 2011, 25:1176-1181.
86. le Roux C.W., et al. Gastric bypass reduces fat intake and preference. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1057-R1066.
87. Shin A.C., et al. 'Liking' and 'wanting' of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1267-R1280.
88. Reimann F., et al. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012, 15:421-431.
89. de Lartigue G., et al. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E187-E195.
90. Zheng H., et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1273-R1282.
91. Wilson-Perez H.E., et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int. J. Obes. (Lond.) 2012, 10.1038/ijo.2012.18.
92. Berthoud H.R., Munzberg H. The lateral hypothalamus as integrator of metabolic and environmental needs: From electrical self-stimulation to opto-genetics. Physiol. Behav. 2011, 104:29-39.